Avocado Oil Market Hit by Fraud Scandal: Labels Mislead Up to 93%

The surge in avocado oil demand has been jolted by a new UC Davis study revealing that many shelf‑stable foods carry counterfeit oil blends.

Lab Findings: Labels Shattered

UC Davis scientists chemically examined 54 avocado‑oil‑labeled products and discovered cheaper oils (canola, safflower) in 48 of them. The analysis showed fraud rates soaring to 93% in certain ready‑to‑eat categories, especially chips, dressings and mayonnaises.

■93% of chips contained adulterated oil

■71% of mayonnaises showed mixing

■100% of dressings failed purity checks

■Only 2% of olive‑oil‑labeled items failed (used as benchmark)

The Real Cost Behind Premium Prices

Avocado‑oil products command a 500% price premium. For instance, a standard mayonnaise on Walmart’s site costs $0.10/oz, while avocado‑oil mayo from Primal Kitchen and Chosen Foods sells at $0.65‑$0.67/oz.

■$0.10/oz regular mayo (Walmart)

■$0.65/oz Primal Kitchen avocado mayo

■$0.67/oz Chosen Foods avocado mayo

■500% price gap misleads consumers

Supply‑Chain Transparency Gaps

Researchers highlighted that most food companies source oils through third‑party brokers and multiple suppliers, leaving little room for rigorous testing. The lack of mandatory lab verification enables adulterated blends to slip into the market.

■Multi‑supplier sourcing

■Absence of compulsory lab testing

■Supplier ignorance vs. intentional dilution

■Weak regulatory oversight compared with olive oil

Brands and Market Dynamics

The study covered products from Chosen Foods, Kettle Brand, Lay's, Lesser Evil, Primal Kitchen, Siete, and Frito‑Lay, among others. These brands market “made with avocado oil” as a premium health claim, yet the actual oil content is far lower.

■Chosen Foods: avocado‑oil chips

■Kettle Brand: avocado‑oil popcorn

■Lay's: avocado‑oil flavored chips

■Primal Kitchen: avocado‑oil mayo

Markets are watching this scandal closely. Avocado oil, a fast‑growing niche in the clean‑label segment, has been posting a 15‑20% annual CAGR; however, a credibility hit could reshape retail pricing and supplier contracts. Investors should prioritize companies that adopt robust quality controls and transparent supply‑chain policies as a hedge against long‑term risk. As fraud disclosures rise, ETF and commodity prices may wobble, while analytical lab firms offering testing services could see a demand boost.